Bioscience Biotechnology Research Communications

An Open Access International Journal

P-ISSN: 0974-6455 E-ISSN: 2321-4007

Bioscience Biotechnology Research Communications

An Open Access International Journal

JOURNAL POLICIES

  • Aims  and Scope
  • Instructions for Authors/MS Submission Guidelines
  • Plagiarism and Ethical Issue Statement
  • Peer Review Process
  • Open Access Policy
  • Article Withdrawal Policy
  • Copyright, Licensing Policy & Privacy Statement
  • Checklist for Authors
  • Guidelines for Reviewers


    Journal Policies

    On Ethical and Animal Welfare Issues:

    Bioscience Biotechnology Research Communications requires that the experimental conditions under which human and animal assays and tests are performed are as per standard protocols used worldwide. Studies on animals must comply with the prevailing standards of animal welfare according to Indian Council of Medical Research Guidelines in India and likewise following similar conditions elsewhere.

    Authors must make it clear in writing that the procedures they used were as humane as possible and have been compiled with the guidelines for animal care of their institutions or with national/ international guidelines.

    Studies involving human subjects must be carried out with the formal approval of the relevant Ethical Committee and evidence of such approval must be provided as and when needed.

    • Plagiarism policyBiosciences, Biotechnology Research Communications follows a strong plagiarism policy. It ensures that none of the part of manuscript is plagiarized from other sources and proper reference is provided for all contents extracted from other sources. Any Manuscript which exceeds the recommended limit of similarity in text will not be considered for sending to the reviewers and will be returned to the authors for revisions. After the approval of the  similarity check levels, further processing of the manuscript will be done.

      All the papers submitted have to pass through an initial screening and will be checked through the Advanced Plagiarism Detection Software (CrossCheck by iThenticate).

    • Open Access PolicyBioscience Biotechnology Research Communications has a policy of Open Access Journals, strictly adhering to the Principles of Transparency and Best Practice in Scholarly Publishing, fulfilling the condition that its authors are copyright holders of their scholarly work, granting usage rights to others using an open acess license (Creative Commons) allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose.

      The full text of all content of Bioscience Biotechnology Research Communications is available for free and has open access without delay with no embargo period.

    • Responsibilities of Authors

    By submitting a manuscript to Biosciences Biotechnology Research Communications, the author(s) warrant that the manuscript is their own, original work and that it has neither been published previously nor is currently being considered for publication elsewhere. They also warrant that the sources of any ideas and/or words in the manuscript that are not their own have been properly attributed through appropriate citations and/or quotes.

    •  An author should not normally publish manuscripts describing essentially the same research in multiple journals or publication venues. Such redundant publication is generally considered to constitute unethical publishing behavior, and if discovered may result in a manuscript under consideration being rejected, or a published article being retracted.Authors of manuscripts reporting on original research should present an accurate account of the work performed, accompanied by an objective discussion of its significance. Underlying data should be represented accurately in the manuscript. The manuscript should contain sufficient detail and references to permit others to replicate the work.

      The fabrication of results and the making of fraudulent or knowingly inaccurate statements constitute unethical behavior and may be cause for rejection or retraction of a manuscript or published article. Where the manuscript reports on commercial software, hardware, or other products, authors must include a declaration at the beginning of the manuscript in which they must either state that no conflict of interest exists or describe the nature of any potential conflict.

      All sources of financial support for the research should also be disclosed in the manuscript. The author(s) of a manuscript agree that if the manuscript is accepted for publication in Biosciences, Biotechnology Research Communications, the published article will be copyrighted using a Creative Commons “Attribution-Non Commercial-Share Alike” license. This license allows the author(s) to retain the copyright, but also allows others to freely copy, distribute, and display the copyrighted work, and derivative works based upon it, under certain specified conditions.

      Authors are responsible for obtaining written permission to include any images or artwork for which they do not hold copyright in their articles, or to adapt any such images or artwork for inclusion in their articles. The copyright holder must be made explicitly aware that the image(s) or artwork will be made freely available online as part of the article under a Creative Commons “Attribution-Non Commercial-Share Alike” license.

      The authors’ names should be listed on the article in order of their contribution to the article, and all authors take responsibility for their own contributions. Only those individuals who have made a substantive contribution should be listed as authors; those whose contributions are indirect or marginal (e.g., colleagues or supervisors who have reviewed drafts of the work or provided proofreading assistance, and heads of research institutes/centers/labs) should be named in an “Acknowledgments” section at the end of the article, immediately preceding the Reference List.

       The corresponding author must ensure that all appropriate co-authors and no inappropriate co-authors are included on the article, and that all listed co-authors have seen and approved the final version of the article and agreed to its publication. Where an author discovers a significant error or inaccuracy in an article of his/hers that has been published in Biosciences, Biotechnology Research Communications, he/she has an obligation to promptly notify the editors and cooperate with them to correct the article or retract it as appropriate.

    Responsibilities of Reviewers
    BBRC’s reviewers perform work for the journal on a volunteer basis. Given that most of these individuals are in full-time employment, their reviewing activities for Biosciences, Biotechnology Research Communications must, by necessity, not be their top priority. Reviewers are free to decline invitations to review particular manuscripts at their discretion, for example, if their current employment workload and/or other commitments make it prohibitive for them to complete a review in a timely fashion and to do justice to the task in the available timeframe. They should also not accept manuscript review assignments for which they feel unqualified.

    Reviewers who have accepted manuscript assignments are normally expected to submit their reviews within three weeks. They should recuse themselves from the assignment if it becomes apparent to them at any stage that they do not possess the required expertise to perform the review, or that they may have a potential conflict of interest in performing the review (e.g., one resulting from competitive, collaborative, or other relationships or connections with any of the authors, institutions, or companies associated with the manuscript).Privileged information or ideas obtained by reviewers through the peer review process must be kept confidential and not used for personal advantage.

    Any manuscripts received for review must be treated as confidential documents, and must not be shown to or discussed with others except as authorized by the Biosciences, Biotechnology Research Communications Editor. When conducting their reviews, reviewers are asked to do so as objectively as possible, refraining from engaging in personal criticism of the author(s). They are encouraged to express their views clearly, explaining and justifying all recommendations made. They should always attempt to provide detailed and constructive feedback to assist the author(s) in improving their work, even if the manuscript is, in their opinion, not publishable.

    Reviewers should identify in their reviews relevant published work that has not been cited by the author(s), together with any instances in which proper attribution of sources has not been provided. They should call to the responsible editor’s attention any major resemblances between a manuscript under consideration and other published articles or papers of which they are aware, as well as any concerns they might have in relation to the ethical acceptability of the research reported in the manuscript.

    Responsibilities of Editors


    The Biosciences, Biotechnology Research Communications Editor has ultimate responsibility for deciding if a manuscript submitted to Biosciences, Biotechnology Research Communications should be published, and in doing so is guided by the journal’s policies as determined by the Biosciences, Biotechnology Research Communications editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement, and plagiarism.

    The Editor may consult with the Associate Editor and other members of the editorial team, as well as with reviewers, in making publication decisions. The editors will evaluate manuscripts for their intellectual content without regard to the race, color, gender, sexual orientation, religious beliefs, ethnic origin, citizenship, or political philosophy of the author(s).

    They will not disclose any information about a manuscript under consideration to anyone other than the author(s), reviewers and potential reviewers, and in some instances the Biosciences, Biotechnology Research Communications editorial board members, as appropriate. Additionally, the editors will make every effort to ensure the integrity of the blind review process by not revealing the identity of the author(s) of a manuscript to the reviewers of that manuscript, and vice versa. When evaluating a manuscript for publication, in addition to considering standard criteria pertaining to the rigor of the manuscript, the quality of its presentation, and its contribution to humanity’s stock of knowledge, the editors will also seek evidence that ethical harms have been minimized in the conduct of the reported research. They will question whether the benefits outweigh the harms in the particular study’s case.

    Since BBRC welcomes the submission of manuscripts from any country, it is necessary to recognize that laws and regulations regarding research ethics and ethical approval vary worldwide. As such, the editors may need to seek clarification in this regard with the author(s) and request that they supply a letter from the relevant institutional ethics committee or board that approved the research.

    The editors will be guided by CORE’s Guidelines for Retracting Articles when considering retracting, issuing an expressions of concern about, and issuing corrections pertaining to articles that have been published in Biosciences, Biotechnology Research Communications. They are committed to working closely with research organizations and institutions in line with CORE’s advice on Cooperation between Research Institutions and Journals on Research Integrity Cases.

    Peer Review Policy

    1. Manuscript Processing

    Upon initial submission of the manuscript, the author will be acknowledged of the receipt via e-mail. Initially an article will be reviewed by one member of the Editorial team to judge the quality of the paper. Articles written in poor English language or not conforming to Biosc. Biotech. Res.Comm guidelines will either be rejected or returned to the authors to rectify the shortcomings. Manuscripts deemed proper should be forwarded to at least two subject experts to provide their unbiased input. Acceptable manuscripts will be checked for data analysis and verification of references before the author will be notified about the status of the paper with any suggestions for modifications. Finally accepted articles should be forwarded to the printer for typeset and formatting, etc. and the proof will be sent to the authors for proof reading, before publication.

    2. Peer Review Policy

    Unbiased, independent, critical assessment is an intrinsic part of all scholarly work, including the scientific process. Peer review is the critical assessment of manuscripts submitted to journals by experts who are not part of the editorial staff, and is, therefore, an important extension of the scientific process. Each article submitted to Biosc. Biotech. Res. Comm for publication is reviewed by at least two specialist reviewers of the concerned area. The   dual review process is strictly followed and in certain controversial cases, the opinion of a 3rd reviewer can also be sought.

    3. Conflict of Interest

    Conflict of interest exists when as author (or the author’s institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationship are also known as dual commitments, competing interests, or competing loyalties). However, conflicts can also occur for other reasons, such as personal relationships, academic competition, and intellectual passion. Increasingly, individual studies receive funding from commercial firms, private foundations, and the government. The conditions of this funding have the potential to bias and otherwise discredit the research. When authors submit a manuscript, they are required to disclose all financial and personal relationships that might bias their work. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist. It is the discretion of editorial committee of   Biosc. Biotech. Res.Comm   to resolve any conflict of interest between the author(s) and reviewers. Editors may choose not to consider an article for publication if they feel that the research is biased by the sponsors funding the research project.

    4. Plagiarism

    Plagiarism is the unauthorized use or close imitation of the language and thoughts of another author and representing them as one’s own original work. Within the academia, it is considered dishonesty or fraud and offenders are subject to academic censure. Plagiarism can be unintentional or intentional, reproducing academic material without appropriate credit to the original authors. Similarly self -plagiarism is the re-use of significant, identical or near identical portions of one’s own work without citing the original work, which is also known as recycling fraud.

    Worst form of plagiarism is to steal the whole article from some journal and publish it under one’s own name in another journal. The Editorial Committee of Biosc. Biotech. Res.Comm will blacklist any author found to be guilty of plagiarism. The name of author(s) committing plagiarism will also be disseminated to editors of other journals.

    5.  Ethical Issues

    Clinical trials and studies conducted in animals (or not) must have been approved by an Institutional Review Committee (IRC). In the absence of such a formal ethics review committee, the Helsinki Declaration of 1975, as revised in 2000 and/or the Guide for the Care and Use of Laboratory Animals, as adopted and promulgated by the United States National Institutes of Health or Indian Council of Medical Research (ICMR) India  must be followed. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. In case of any study involving clinical trial, taking of informed consent of patients is mandatory.

    6.  Editorial Committee

    The Editorial committee consisting of the Editor- in-Chief, Associate Editor, Editors, Assistant Editor(s) and the editorial secretaries meet frequently to expedite the business of the journal. The editorial committee follows the guidelines provided by the International Committee of Medical Journal Editors in Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication which can be downloaded from http://www.icmje.org/

    7. Advisory Board

    An advisory board comprising of members with significant professional experience in different fields of biological and biomedical sciences helps the Editorial Committee in policy matters when needed. Senior advisory board members from India as well as abroad are members of the journal. Each member has been selected due to the expertise and experience in the field of their specializations.

    Article Withdrawal Policy

    Submission of an article to Biosc. Biotech. Res.Comm implies that the work has NOT been published or submitted elsewhere, therefore, the journal is strongly against unethical withdrawal of an article from the publication process after submission. Once the article is submitted, the author grants the editorial board full publishing rights and it is the absolute right of the editorial board to decide on article withdrawals. For genuine withdrawal, the corresponding author should submit a request which must be signed by all co-authors explaining the explicit reasons of withdrawing the manuscript.

    Accepted articles in final stages of publication if are withdrawn, will entail withdrawal fees. The request will be processed by the editorial board and only serious genuine reasons will be considered if possible. The decision of the editorial board will be final and not negotiable. Unethical withdrawal or no response from the authors to editorial board communication will be subjected to sanction a ban to all authors, and their institute will also be notified.

    Copy Right and Licensing Policy

    Copyright

    Biosc Biotech Res Comm has a policy of copy right, where all the published content of its scholarly articles by its authors can be used for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose.

    All articles published by Biosc Biotech Res Comm will be distributed Freely under the terms and conditions of the Creative Commons Attribution License (CC-BY) https://creativecommons.org/licenses/by/4.0/.

    Thus, any one is freely allowed to copy, distribute, and transmit the article on condition that the original article and source is correctly cited.

    Licensing Policy

    Biosc Biotech Res Comm has a policy of licensing for use and re- use of the published content without any embargo period, following policy that its authors are copyright holders of their scholarly work, granting usage rights to others using Creative Commons licenses for this purpose. 

    Privacy Statement

    The names and email addresses entered in the journal site will be used exclusively for the stated purposes of the journal and will not be made available for any other purpose and will not be shared to any other party.

    Complaint Policy

    Genuine complaints in Publication: Complaint or expression of dissatisfaction made in honest intention of improvisation are always welcome, as they provide an opportunity and instant moment of attaining quality.The editorial team of Bioscience Biotechnology Research Communications shall strive hard to establish, along with the publisher, a transparent mechanism for appeal against editorial decisions or any related matter of publication. If still there are any genuine complaints related to ethical publishing, we are always open to them for the sake of maintaining quality and ethics of publication.

    Please write your complaint with Journal title, Vol. No. Issue No. Year Page numbers, full title of the MS and necessary author details along with type of complaint. The complaint must be about something that is within the jurisdiction of Bioscience Biotechnology Research Communications, its contents or process such as authorship, plagiarism, copy right violation, multiple, duplicate, or concurrent publications / simultaneous submissions etc. Similarly, undisclosed conflicts of interest, reviewer bias or competitive harmful acts by reviewers or any bias of apparent discontentment, backed by logic and judicial discretion will be immediately looked into without any bias and discrimination.


    If the Editor receives a complaint that any contribution to the Journal breaks intellectual property rights or contains material inaccuracies or otherwise unlawful materials, a detailed investigation may be requested into, with the parties involved,substantiating their materialistic claims in writing, following the law of natural justice.

    We assure that we will make a good faith determination to remove the allegedly wrongful material or take actions as per law.All the investigations and decisions are to be documented to the Journal.Our aim is to ensure that Bioscience Biotechnology Research Communications follows best practices in publication and is of the highest quality, free from errors. However, we accept that occasionally mistakes might happen, which are inadvertently made or beyond human control, giving opportunity to all parties to decide the best to rectify.

    Editorial Complaints Policy: The Managing Editor and staff of Bioscience Biotechnology Research Communications will make every efforts to put matters right as soon as possible in the most appropriate way, offering right of reply where necessary. As far as possible, we will investigate complaints in a blame-free manner, looking to see how systems can be improved to prevent mistakes occurring.


    How to Make a Complaint: Complaints about editorial content should be made as soon as possible after publication, preferably in writing by email to editor@bbrc,inor by on-line submission at www.bbrc.in.

    Publication Charges / Waiver Policy: The journal is an open access journal which means that all the contents are easily available and accessible to any of the explorers without any charges. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal subject to proper citation and acknowledgements.

    Biosc.Biotech.Res.Comm. does not have any Article Submission Charges

    For Editors: We invite articles from our members of the editorial advisory board free of cost.

    For Reviewers: Reviewers who review the manuscripts within the stipulated time according to the journal are given a 30% waiver on the article processing charges for one manuscript submitted in a calendar year.

    For Authors: On request the editorial committee of BBRC can provide a significant  waiver of  the Article Processing Charges (APC) based on the quality of research work  and the country of the contributors, encouraging authors  from developing countries.

          
     A New Edition of Web of Science
    Thomson Reuters ISI Web of Science Now
    Clarivate Analytics ESCI Wos USA

    Cross Reference USA

    Biosc. Biotech. Res. Comm.  Referenced in NCBI DBs NCBI National Library of Medicine (NLM)  USA.

    NLM ID: 101703647(Serial)
    NLM Title Abbreviation :Biosc. Biotech.Res.Comm.
          Google Scholar Citations